• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[单机构45例环状软骨后癌患者的外科治疗]

[Surgical treatment of 45 patients with postcricoid carcinoma at a single institute].

作者信息

Wei D M, Li W M, Qian Y, Cao S D, Liu D Y, Pan X L, Lei D P

机构信息

Department of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission Key Laboratory of Otorhinolaryngology (Shandong University), Jinan 250012, China.

Department of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission Key Laboratory of Otorhinolaryngology (Shandong University), Jinan 250012, China; Department of Otorhinolaryngology Head and Neck Surgery, Qilu Hospital of Shandong University (Qingdao), Qingdao 266100, China.

出版信息

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Dec 7;55(12):1120-1125. doi: 10.3760/cma.j.cn115330-20200626-00528.

DOI:10.3760/cma.j.cn115330-20200626-00528
PMID:33342126
Abstract

To evaluate the oncologic and functional outcomes of postcricoid carcinoma treated by surgical treatment, and to summarize our clinical experience in surgical treatment and reconstructive techniques. Medical files of 45 patients were collected and retrospectively analyzed. The patients received surgical treatments between January 2010 and May 2017 in the Qilu Hospital of Shandong University, including 39 males and 6 females, the age ranged from 41 to 78 years old. T1, T2, T3 and T4 staging tumors represented respectively for 2,13,23 and 7 cases. And cervical metastasis was histologically identified in 33 cases (8 for N1 and 25 for N2). Advanced staging patients (10 in Stage Ⅲ and 30 in Stage Ⅳ) accounted for 88.9% of the cohort, while early staging cases (1 in Stage Ⅰand 4 in Stage Ⅱ) for 10.1%. All patients received cervical lymph node dissection. After tumor excision without compromising margins, hypopharyngeal functions were reconstructed by residual mucosa, pectoralis major myocutaneous flap, laryngotracheal tissue flap or gastric tissue flap, and laryngeal functions were reconstructed by epiglottis, sternohyoid myofascial flap or thyroid perichondrium. Survival rates were analyzed by the Kaplan-Meier method. Postoperatively 23 patients received radiotherapy and 13 patients received chemoradiotherapy. All patients were followed up for more than 3 years. Total 3-year and 5-year survival rates were 60.5% and 49.0%, respectively. Patients obtaining the conservation of laryngeal functions accounted for 44% (20/45) of all cases. The neck lymph node positive rate was 73.3%(33/45), and log-rank test demonstrated that cervical lymph node metastasis was significantly associated with prognosis of patients (χ(2)=4.364, =0.037). Appropriate surgical approaches and excision methods and comprehensive application of flaps are critical to precise tumor excision and reconstruction of laryngeal functions, thereby improving the quality of life of patients with posterior carcinoma.

摘要

评估环状软骨后癌手术治疗的肿瘤学和功能结局,并总结我们在手术治疗及重建技术方面的临床经验。收集并回顾性分析45例患者的病历资料。这些患者于2010年1月至2017年5月在山东大学齐鲁医院接受手术治疗,其中男性39例,女性6例,年龄范围为41至78岁。T1、T2、T3和T4分期的肿瘤分别为2例、13例、23例和7例。经组织学检查发现33例有颈部转移(N1为8例,N2为25例)。晚期分期患者(Ⅲ期10例,Ⅳ期30例)占该队列的88.9%,而早期分期病例(Ⅰ期1例,Ⅱ期4例)占10.1%。所有患者均接受了颈部淋巴结清扫术。在确保切缘阴性的肿瘤切除术后,下咽功能通过残余黏膜、胸大肌肌皮瓣、喉气管组织瓣或胃组织瓣进行重建,喉功能通过会厌、胸骨舌骨肌筋膜瓣或甲状腺软骨膜进行重建。采用Kaplan-Meier法分析生存率。术后23例患者接受了放疗,13例患者接受了放化疗。所有患者均随访3年以上。3年和5年总生存率分别为60.5%和49.0%。保留喉功能的患者占所有病例的44%(20/45)。颈部淋巴结阳性率为73.3%(33/45),对数秩检验表明颈部淋巴结转移与患者预后显著相关(χ(2)=4.364,P=0.037)。合适的手术入路和切除方法以及皮瓣的综合应用对于精确切除肿瘤和重建喉功能至关重要,从而提高环状软骨后癌患者的生活质量。

相似文献

1
[Surgical treatment of 45 patients with postcricoid carcinoma at a single institute].[单机构45例环状软骨后癌患者的外科治疗]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Dec 7;55(12):1120-1125. doi: 10.3760/cma.j.cn115330-20200626-00528.
2
[Surgical treatment in 184 patients with supraglottic carcinoma at a single institute].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 May 7;54(5):334-338. doi: 10.3760/cma.j.issn.1673-0860.2019.05.004.
3
[Treatment and prognosis of 264 patients with hypopharyngeal carcinoma].264例下咽癌患者的治疗与预后
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 May 7;53(5):346-351. doi: 10.3760/cma.j.issn.1673-0860.2018.05.004.
4
[Prognostic factors affecting results of comprehensive treatment of hypopharyngeal carcinoma].[影响下咽癌综合治疗效果的预后因素]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Jul;49(7):533-8.
5
[Efficacy of surgical comprehensive therapy for 456 cases of hypopharyngeal carcinoma].[手术综合治疗456例下咽癌的疗效]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Jun 7;58(6):558-564. doi: 10.3760/cma.j.cn115330-20221201-00724.
6
[Characteristics of cervical lymph node metastasis of cN0 laryngeal carcinoma].[cN0期喉癌颈淋巴结转移的特征]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 May 7;54(5):343-348. doi: 10.3760/cma.j.issn.1673-0860.2019.05.006.
7
[Surgery for T4 hypopharyngeal cancer and reconstruction after hypopharyngo-oesphagectomy].[T4期下咽癌手术及下咽-食管切除术后重建]
Zhonghua Zhong Liu Za Zhi. 2011 Mar;33(3):222-5.
8
[An attempt to evaluate prognosis in cases of metastasis from laryngeal and hypopharyngeal carcinoma to cervical lymph nodes].[评估喉癌和下咽癌转移至颈部淋巴结病例预后的尝试]
Ann Acad Med Stetin. 1996;42:157-76.
9
[Surgical management of aged patients with hypopharyngeal carcinoma and preservation of laryngeal function].老年下咽癌患者的手术治疗及喉功能保留
Ai Zheng. 2005 Nov;24(11):1372-5.
10
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.喉和下咽鳞状细胞癌的区域转移延迟、远处转移及第二原发性恶性肿瘤
Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028.

引用本文的文献

1
Oncological Analysis and Surgical Outcomes in Postcricoid Carcinoma: A 14 Years Retrospective Study.环状软骨后癌的肿瘤学分析及手术结果:一项14年的回顾性研究
Cancers (Basel). 2022 Jun 27;14(13):3146. doi: 10.3390/cancers14133146.